Tag: HP-MAP
Vaxxas’ needle-free seasonal influenza vaccine enters clinical trial
Vaxxas has commenced the Phase I clinical trial of the first needle-free inactivated seasonal influenza vaccine quadrivalent (IIV4) candidate via its proprietary high-density microarray patch (HD-MAP) technology.
Featured Article
AI & Manufacturing Month with Australian Manufacturing
As industries around the globe embrace the digital revolution, artificial intelligence (AI) is rapidly transforming the manufacturing landscape.Â
